Skip to content

Study · Not a test of the peptide alone · 1990

2 results

[Immunoreactive disorders and their correction in patients with rhegmatogenous retinal detachment complicated by vitreoretinal proliferation].

Vanichkin AA, Kovalev AI, Mikhaĭlova TP

Oftalmologicheskii zhurnal1 Jan 1990

PMID2092253 (opens in a new tab)PepBankPUB-02092253
Publisher pageAsk about this study
Jump to 2 results

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study2

No result from this study comes from a test of the peptide.

Studies that did not test the peptide alone2

In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. These results are not evidence about taking Thymalin.

  1. 01HumanNot a test of Thymalin aloneNon-randomized trialEfficacy outcome

    In patients with complicated rhegmatogenous retinal detachment, complex treatment with thymaline increased treatment effectiveness in 78% of patients.

    In plain wordsIn patients with complicated retinal detachment, complex treatment with thymaline increased treatment effectiveness in 78% of patients.

    Peptide
    Thymalin
    Outcome
    IncreaseTreatment effectiveness
    Study

    n = 17

    Outcome group
    Vision and retina · Eye

    Measurements

    Patients with increased treatment effectiveness
    78%
    Complex treatment with thymaline

    Source sentences

    Summary
    The preparation rose the effectiveness of the treatment in 78% of patients and reduced the number of postoperative complications.
    1 context sentence
    Summary · context
    For normalization of the revealed disturbances in the immune state, immunomodulator thymaline was used in a complex treatment of 17 patients.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

  2. 02HumanNot a test of Thymalin aloneNon-randomized trialSafety outcome

    In patients with complicated rhegmatogenous retinal detachment, complex treatment with thymaline reduced postoperative complications.

    In plain wordsIn patients with complicated retinal detachment, complex treatment with thymaline reduced postoperative complications.

    Peptide
    Thymalin
    Outcome
    DecreasePostoperative complications
    Study

    n = 17

    Outcome group
    Adverse events · Eye

    Source sentences

    Summary
    The preparation rose the effectiveness of the treatment in 78% of patients and reduced the number of postoperative complications.
    1 context sentence
    Summary · context
    For normalization of the revealed disturbances in the immune state, immunomodulator thymaline was used in a complex treatment of 17 patients.

    In this study, Thymalin was a lab tool or a carrier, part of a mix, or the subject of a lab method. This result is not evidence about taking Thymalin.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    14 Oct 2026, 05:02 UTC

    Study results updated

  2. Version 1

    14 Oct 2026, 01:46 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

PepBank is a research reference. Talk to a doctor before you use any peptide.